Location: Home
  • search
  • go
  • Relate News
  • 9/26/2024CDE Issues the Technical Guidelines for Vaccine Immunogenicity Bridgin...
  • 9/26/2024CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
  • 9/26/2024China Issues the Provisions for Investigator-Initiated Clinical Resear...
  • 9/26/2024Bayer Opens First Co.Lab in China in Shanghai
  • 9/24/2024LongBio Secures CNY 100M in Series B2 Financing to Advance Antibody Th...
  • 9/23/2024AstraZeneca Korea Launches Open Innovation Program to Support Korean B...
  • 9/23/2024Is Biotech the Next Battleground in US-China Decoupling? (SCMP)
  • 9/20/2024Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain
  • 9/20/2024Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...
  • 9/20/2024Ocumension Therapeutics's ZERVIATE Approved in China
  • 9/20/2024NMPA Deputy Commissioner Meets with Danish Delegation
  • 9/20/2024NHC Issues the Notice on Further Advancing Clinical Nutrition Work
  • 9/20/2024Recent Executive Moves
  • 9/20/2024China to Raise Retirement Age to 63 Amid Growing Pressure from Aging P...
  • 9/19/2024Celregen Thera Secures CNY Multi-Millions in Angel Round Financing
  • 9/19/2024CDE Issues the Technical Guidelines for Clinical Trials of Cardiac Arr...
  • 9/19/2024CDE Issues the Technical Guidelines for Clinical Design of Denosumab I...
  • 9/19/2024Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
  • 9/19/2024Kenvue Targets Innovation to Capitalize on China's Expanding Consumer ...
  • 9/19/2024China's Implementation of Patent Term Adjustment (SM)
  • 9/18/2024China to Accelerate Approval of Innovative Drugs and Medical Devices, ...
  • 9/17/2024NHSA Announces Conclusion of Expert Evaluation for 2024 DRDL Inclusion...
  • 9/17/2024NHC's Annual Statistical Report on China Healthcare Sector Development...
  • 9/17/2024Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
  • 9/13/2024Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
  • 9/13/2024CDE Issues the Pilot Work Plan for Patient-Centered Rare Disease Drug ...
  • 9/13/2024NHSA and MOF Jointly Issue Reform Policies Relatinng to Direct Settlem...
  • 9/13/2024Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
  • 9/13/2024China Courts Global Pharma with Promises of Faster Drug Approvals and ...
  • 9/13/2024China Reports Increase in Innovative Drug Approvals
  • Page:36/761 Total number of articles:22830: [First][<<] [34] [35] [36] [37] [38] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group